Touchstone
Last syncOct 31, 2026, 6:54 PM ET

CON

Concentra Group Holdings Parent, Inc. Health Care Services-Specialty Outpatient Facilities, NEC Russell 3000
$40.38Close $5.2BMarket cap $18.52 – $41.2552-week range Nov 5, 2026Next report · after the close
Stage 2 Leader 39th of 68

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 95 · stronger than 95% of stocks over 12 months
  • Near its high 2% below its 52-week high
  • Earnings growing EPS +47% year on year, faster than the quarter before (+18 pts)

Cautions

  • Extended 4.8 ATR above its 50-day average
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 2%
1wk up 2.9% price change
1mo up 17.3% price change
12-month return up 103% market up 11% · its own up 92%
F-score — — Not assessed
Altman Z″ 1.23 Moderate risk
P/E 31.2× price / earnings
PEG — P/E / EPS growth
P/B 13.2× price / book
Earnings yield up 5.0% EBIT / enterprise value
Cheaper than 44% of the market · around average
Revenue growth up 14% year on year
EPS growth up 47% latest quarter · +18 pts
Sales growth up 10% latest quarter · -4 pts
ROE up 50% return on equity
Free cash margin up 9% $197.1M FCF
D/E 3.98 long-term debt / equity
Net debt / EBITDA 3.6×
Interest cover —EBIT / interest

Trade setup

ATR% 2.3% $0.93 a day · 2×ATR $38.52
RS 95 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.0× vs 50-day average
Up/down volume 1.14 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 8 of 8

Screen verdict

1 of 3 screens
  • Stage 2 Leader in mixed conditions
    • RS 95
    • Trend 8/8
    • Off 12-month high 2%
    • EPS growth +47% (accel +18 pts)
    • Sales growth +10% (accel -4 pts)
    • Altman Z″ 1.23 (moderate risk)

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+10% vs market2 sessions after results

Financials

4 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.2B +14% on FY2024
$0 $2.5B FY22 FY23 FY24 FY25 FY2022 · $1.7B FY2023 · $1.8B FY2024 · $1.9B FY2025 · $2.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $166.4M -0.1% on FY2024
$0 $200M FY22 FY23 FY24 FY25 FY2022 · $166.7M FY2023 · $179.9M FY2024 · $166.5M FY2025 · $166.4M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $197.1M -6% on FY2024
$0 $250M FY22 FY23 FY24 FY25 FY2022 · $228.4M FY2023 · $169.4M FY2024 · $210.3M FY2025 · $197.1M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 8%
  • Free cash 9%
0% 20% FY22 FY23 FY24 FY25 FY2022 · Net 10% · Free cash 13% FY2023 · Net 10% · Free cash 9% FY2024 · Net 9% · Free cash 11% FY2025 · Net 8% · Free cash 9%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.5B net debt
  • Cash
  • Long-term debt
$0 $2B FY22 FY23 FY24 FY25 FY2022 · Cash $37.7M FY2023 · Cash $31.4M · Long-term debt $3.3M FY2024 · Cash $183.3M · Long-term debt $1.5B FY2025 · Cash $79.9M · Long-term debt $1.6B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 128.63m
128.63m 128.13m FY22 FY23 FY24 FY25 FY2022 FY2023 FY2024 · 128.13m FY2025 · 128.63m
  FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.7B $1.8B $1.9B $2.2B
Operating income $258.5M $287.6M $304.8M $334.0M
Net income $166.7M $179.9M $166.5M $166.4M
Net margin 10% 10% 9% 8%
Earnings per share $1.61 $1.73 $1.46 $1.30
Free cash flow $228.4M $169.4M $210.3M $197.1M
Free cash margin 13% 9% 11% 9%
Cash $37.7M $31.4M $183.3M $79.9M
Long-term debt — $3.3M $1.5B $1.6B
Shareholders' equity $979.3M $1.2B $275.7M $393.3M
Shares outstanding — — 128.13m 128.63m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Mar 3, 2025 Annual ↗ Dec 31, 2024 62d
Nov 6, 2024 Quarterly ↗ Sep 30, 2024 37d
Aug 27, 2024 Quarterly ↗ Jun 30, 2024 58d

Current reports

FiledDisclosed
Sep 8, 2026 Director or officer change · Regulation FD ↗
Aug 27, 2026 Material agreement ↗
Aug 6, 2026 Results · Director or officer change · Regulation FD · Other events ↗
Jul 10, 2026 Director or officer change ↗
May 7, 2026 Results · Regulation FD · Other events ↗
Apr 30, 2026 Shareholder vote ↗
Apr 14, 2026 Director or officer change · Regulation FD ↗
Feb 26, 2026 Results · Regulation FD · Other events ↗
Jan 28, 2026 Results · Regulation FD ↗
Jan 12, 2026 Results · Regulation FD ↗
Nov 10, 2025 Director or officer change ↗
Nov 6, 2025 Results · Regulation FD · Other events ↗